Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Camelina sativa variety “SO-70”

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Publication Date:
    November 01, 2022
  • معلومة اضافية
    • Patent Number:
      11483,992
    • Appl. No:
      17/168518
    • Application Filed:
      February 05, 2021
    • نبذة مختصرة :
      The subject invention relates to a Camelina sativa (L.) Crantz spring-type seed designated as “SO-70” derived from a three-way cross between Camelina accessions with high yield and oil quality attributes following conventional breeding methodologies.
    • Inventors:
      Sustainable Oils, Inc. (Torrance, CA, US)
    • Assignees:
      SUSTAINABLE OILS, INC. (Torrance, CA, US)
    • Claim:
      1. A seed of Camelina sativa (L.) variety designated “SO-70,” wherein a representative sample of seed of said variety has been deposited under ATCC Accession No. PTA-126935.
    • Claim:
      2. A Camelina sativa (L.) plant, or a part thereof, produced by growing the seed of claim 1 .
    • Claim:
      3. A Camelina sativa (L.) plant, or a part thereof, having all the physiological and morphological characteristics of Camelina sativa (L.) variety “SO-70,” wherein a representative sample of seed of said variety has been deposited under ATCC Accession No. PTA-126935.
    • Claim:
      4. A tissue culture of regenerable cells produced from the plant or plant part of claim 2 .
    • Claim:
      5. The tissue culture of claim 4 , wherein said cells of the tissue culture are produced from a plant part selected from the group consisting of embryos, meristematic cells, leaves, pollen, root, root tips, stems, anther, pistils, pods, flowers and seeds.
    • Claim:
      6. A Camelina sativa (L.) plant regenerated from the tissue culture of claim 5 , said plant having the morphological and physiological characteristics of Camelina sativa (L.) variety “SO-70,” wherein a representative sample of seed has been deposited under ATCC Accession No. PTA-126935.
    • Claim:
      7. A method for producing a Camelina seed comprising crossing a first parent Camelina plant with a second parent Camelina plant and harvesting the resultant hybrid bean seed, wherein said first parent Camelina plant or second parent Camelina plant is the Camelina sativa (L.) plant of claim 2 .
    • Claim:
      8. A hybrid Camelina seed produced by the method of claim 7 .
    • Claim:
      9. A method for producing an herbicide-resistant Camelina plant comprising transforming the Camelina saliva (L.) plant of claim 2 with a transgene that confers herbicide resistance to an herbicide selected from the group consisting of imidazolinone, sulfonylurea, glyphosate, glufosinate, L-phosphinothricin, triazine, and benzonitrile.
    • Claim:
      10. An herbicide resistant Camelina plant, or a part thereof, produced by the method of claim 9 .
    • Claim:
      11. A method for producing an insect resistant Camelina plant comprising transforming the Camelina saliva (L.) plant of claim 2 with a transgene that confers insect resistance.
    • Claim:
      12. An insect resistant Camelina plant, or a part thereof, produced by the method of claim 11 .
    • Claim:
      13. A method for producing a disease resistant Camelina plant comprising transforming the Camelina sativa (L.) plant of claim 2 with a transgene that confers disease resistance.
    • Claim:
      14. A disease resistant Camelina plant, or a part thereof, produced by the method of claim 13 .
    • Claim:
      15. A method of introducing a desired trait into Camelina sativa (L.) variety “SO-70” comprising: (a) crossing a Camelina saliva (L.) variety “SO-70” plant grown from Camelina saliva (L.) variety “SO-70” seed, wherein a representative sample of seed has been deposited under ATCC Accession No. PTA-126935, with another Camelina plant that comprises a desired trait to produce F1 progeny plants; (b) selecting one or more progeny plants that have the desired trait to produce selected progeny plants; (c) crossing the selected progeny plants with the Camelina saliva (L.) variety “SO-70” plants to produce backcross progeny plants; (d) selecting for backcross progeny plants that have the desired trait and physiological and morphological characteristics of Camelina saliva (L.) variety “SO-70” to produce selected backcross progeny plants; and (e) repeating steps (c) and (d) three or more times in succession to produce selected fourth or higher backcross progeny plants that comprise the desired trait and the physiological and morphological characteristics of Camelina saliva (L.) variety “SO-70”.
    • Claim:
      16. A Camelina plant produced by the method of claim 15 , wherein the plant has the desired trait and otherwise all the physiological and morphological characteristics of Camelina saliva (L.) variety “SO-70.”
    • Claim:
      17. A method for producing Camelina saliva (L.) variety “SO-70” seed comprising crossing a first parent Camelina saliva (L.) plant with a second parent Camelina saliva (L.) plant and harvesting the resultant Camelina saliva (L.) seed, wherein both said first and second Camelina saliva (L.) plants are the Camelina saliva (L.) plant of claim 4 .
    • Claim:
      18. The Camelina plant of claim 16 , wherein the desired trait is herbicide resistance and the resistance is conferred to an herbicide selected from the group consisting of imidazolinone, sulfonylurea, glyphosate, glufosinate, L-phosphinothricin, triazine, and benzonitrile.
    • Claim:
      19. The Camelina plant of claim 16 , wherein the desired trait is insect resistance and the insect resistance is conferred by a transgene encoding a Bacillus thuringiensis endotoxin.
    • Claim:
      20. The Camelina plant of claim 16 , wherein the desired trait is selected from the group consisting of insect resistance, disease resistance, water stress tolerance, heat tolerance, improved shelf life, and improved nutritional quality.
    • Patent References Cited:
      8319021 November 2012 Guillen-Portal
      2011/0239323 September 2011 Hutcheon et al.
      2012/0124694 May 2012 Guillen-Portal
      2013/0117887 May 2013 Kaijalainen et al.
      0238779 May 2002
      2009117555 September 2009
    • Primary Examiner:
      McElwain, Elizabeth F
    • Attorney, Agent or Firm:
      Saliwanchik, Lloyd & Eisenschenk
    • الرقم المعرف:
      edspgr.11483992